![James M. Coull](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James M. Coull
Nessuna posizione attualmente
Profilo
James M.
Coull is the founder of Boston Probes, Inc. He worked as a Senior Director of Research & Development at EMD Millipore Corp.
and PerSeptive Biosystems, Inc. He also worked as a VP of Commercial Operations & Chief Technology Officer at Ensemble Therapeutics Corp.
and as a Vice President of Business Development at AdvanDx, Inc. Dr. Coull received his undergraduate degree from Colby College and his doctorate degree from Purdue University.
Precedenti posizioni note di James M. Coull
Società | Posizione | Fine |
---|---|---|
PerSeptive Biosystems, Inc.
![]() PerSeptive Biosystems, Inc. Medical SpecialtiesHealth Technology PerSeptive Biosystems developed and manufactured an integrated system for the purification, analysis, and synthesis of bio-molecules, reducing the time and cost of drug discoveries. BVP’s Chris Gabrieli invested in the company’s second round in December 1989. PerSeptive was purchased by Perkin Elmer, Inc. (NYSE: PKI) in 1998, it is a part of Applied Biosystems (NYSE: ABI), a subsidiary of Applera, Perkin Elmer’s former biotechnology division | Direttore Tecnico/Scientifico/R&S | - |
EMD Millipore Corp.
![]() EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Direttore Tecnico/Scientifico/R&S | - |
Ensemble Therapeutics Corp.
![]() Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | - |
Boston Probes, Inc.
![]() Boston Probes, Inc. Medical SpecialtiesHealth Technology Boston Probes, Inc. developed peptide nucleic acid probe-based systems for human cytogenetics. The company was founded by James M. Coull and Brian D. Gildea and was headquartered in Waltham, MA. | Fondatore | - |
AdvanDx, Inc.
![]() AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di James M. Coull
Purdue University | Doctorate Degree |
Colby College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
AdvanDx, Inc.
![]() AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Health Technology |
Ensemble Therapeutics Corp.
![]() Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Process Industries |
Boston Probes, Inc.
![]() Boston Probes, Inc. Medical SpecialtiesHealth Technology Boston Probes, Inc. developed peptide nucleic acid probe-based systems for human cytogenetics. The company was founded by James M. Coull and Brian D. Gildea and was headquartered in Waltham, MA. | Health Technology |
EMD Millipore Corp.
![]() EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
PerSeptive Biosystems, Inc.
![]() PerSeptive Biosystems, Inc. Medical SpecialtiesHealth Technology PerSeptive Biosystems developed and manufactured an integrated system for the purification, analysis, and synthesis of bio-molecules, reducing the time and cost of drug discoveries. BVP’s Chris Gabrieli invested in the company’s second round in December 1989. PerSeptive was purchased by Perkin Elmer, Inc. (NYSE: PKI) in 1998, it is a part of Applied Biosystems (NYSE: ABI), a subsidiary of Applera, Perkin Elmer’s former biotechnology division | Health Technology |
- Borsa valori
- Insiders
- James M. Coull